Department of Clinical Studies and Animal Biology, School of Veterinary Medicine, The University of Pennsylvania, Philadelphia 19104-4539, USA.
Wound Repair Regen. 2013 May-Jun;21(3):382-94. doi: 10.1111/wrr.12044. Epub 2013 Apr 29.
Veterinarians and veterinary medicine have been integral to the development of stem cell therapies. The contributions of large animal experimental models to the development and refinement of modern hematopoietic stem cell transplantation were noted nearly five decades ago. More recent advances in adult stem cell/regenerative cell therapies continue to expand knowledge of the basic biology and clinical applications of stem cells. A relatively liberal legal and ethical regulation of stem cell research in veterinary medicine has facilitated the development and in some instances clinical translation of a variety of cell-based therapies involving hematopoietic stem cells and mesenchymal stem cells, as well as other adult regenerative cells and recently embryonic stem cells and induced pluripotent stem cells. In fact, many of the pioneering developments in these fields of stem cell research have been achieved through collaborations of veterinary and human scientists. This review aims to provide an overview of the contribution of large animal veterinary models in advancing stem cell therapies for both human and clinical veterinary applications. Moreover, in the context of the "One Health Initiative," the role veterinary patients may play in the future evolution of stem cell therapies for both human and animal patients will be explored.
兽医和兽医医学一直是干细胞治疗发展的重要组成部分。早在近五十年前,大型动物实验模型就为现代造血干细胞移植的发展和完善做出了贡献。最近,成人干细胞/再生细胞治疗的进展不断扩展了对干细胞基础生物学和临床应用的认识。相对宽松的兽医干细胞研究的法律和伦理规定促进了各种基于细胞的疗法的发展,在某些情况下已经进行了临床转化,这些疗法涉及造血干细胞和间充质干细胞,以及其他成人再生细胞,最近还包括胚胎干细胞和诱导多能干细胞。事实上,这些干细胞研究领域中的许多开创性发展都是通过兽医和人类科学家的合作实现的。本综述旨在概述大型动物兽医模型在推进人类和临床兽医应用的干细胞治疗方面的贡献。此外,在“同一健康倡议”的背景下,将探讨兽医患者在未来人类和动物患者的干细胞治疗发展中可能发挥的作用。